Meeting report: tumor biology--how signaling processes translate to therapy.
On the occasion of the 10th Joint Meeting "Signal Transduction-Receptors, Mediators and Genes" in November 2006, the Signal Transduction Society (STS) focused on the holy grail of translational research, that is, how basic signaling research might be transferred into cancer therapy. Participants heard of blockbusters and setbacks and learned of new therapeutic approaches that concentrate on distinct signaling pathways at a more individual level. Thus, the young STS community and the 300 meeting participants left with an optimistic outlook and the notion that the translational task will keep scientists busy all over the world for a while.
Friedrich
Karlheinz
K
Institute of Biochemistry, Friedrich-Schiller University, Jena, Germany.
Janssen
Ottmar
O
Hass
Ralf
R
D000818:Animals; D015972:Gene Expression Regulation, Neoplastic; D005858:Germany; D006801:Humans; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism / Q000628:therapy; D015398:Signal Transduction; D012958:Societies, Scientific
D009363:Neoplasm Proteins